Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase

Prostaglandins Other Lipid Mediat. 2016 Mar:123:16-27. doi: 10.1016/j.prostaglandins.2016.02.003. Epub 2016 Feb 27.

Abstract

Arachidonic acid (AA) and the related prostanoids exert complex effects on the adipocyte differentiation depending on the culture conditions and life stages. Here, we investigated the effect of the pretreatment of cultured 3T3-L1 preadipocytes with exogenous AA during the differentiation phase without 3-isobutyl-1-methylxanthine (IBMX), a cAMP-elevating agent, on the storage of fats after the maturation phase. This pretreatment with AA stimulated appreciably adipogenesis after the maturation phase as evident with the up-regulated gene expression of adipogenic markers. The stimulatory effect of the pretreatment with AA was attenuated by the co-incubation with each of cyclooxygenase (COX) inhibitors. Among exogenous prostanoids and related compounds, the pretreatment with MRE-269, a selective agonist of the IP receptor for prostaglandin (PG) I2, strikingly stimulated the storage of fats in adipocytes. The gene expression analysis of arachidonate COX pathway revealed that the transcript levels of inducible COX-2, membrane-bound PGE synthase-1, and PGF synthase declined more greatly in cultured preadipocytes treated with AA. By contrast, the expression levels of COX-1, cytosolic PGE synthase, and PGI synthase remained constitutive. The treatment of cultured preadipocytes with AA resulted in the decreased synthesis of PGE2 and PGF2α serving as anti-adipogenic PGs although the biosynthesis of pro-adipogenic PGI2 was up-regulated during the differentiation phase. Moreover, the gene expression levels of EP4 and FP, the respective prostanoid receptors for PGE2 and PGF2α, were gradually suppressed by the supplementation with AA, whereas that of IP for PGI2 remained relatively constant. Collectively, these results suggest the predominant role of endogenous PGI2 in the stimulatory effect of the pretreatment of cultured preadipoccytes with AA during the differentiation phase without IBMX on adipogenesis after the maturation phase.

Keywords: Adipogenesis; Arachidonic acid; Differentiation phase; Preadipocyte; Prostaglandin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine
  • 3T3-L1 Cells
  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Acetates / pharmacology
  • Adipocytes / cytology
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Adipogenesis / drug effects*
  • Adipogenesis / genetics
  • Animals
  • Arachidonic Acid / pharmacology*
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Dinoprost / metabolism
  • Dinoprostone / metabolism
  • Gene Expression Regulation / drug effects*
  • Humans
  • Hydroxyprostaglandin Dehydrogenases / genetics
  • Hydroxyprostaglandin Dehydrogenases / metabolism
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Mice
  • Prostaglandin-E Synthases / genetics
  • Prostaglandin-E Synthases / metabolism
  • Pyrazines / pharmacology
  • Receptors, Prostaglandin / antagonists & inhibitors
  • Receptors, Prostaglandin / genetics
  • Receptors, Prostaglandin / metabolism
  • Receptors, Prostaglandin E, EP4 Subtype / antagonists & inhibitors
  • Receptors, Prostaglandin E, EP4 Subtype / genetics
  • Receptors, Prostaglandin E, EP4 Subtype / metabolism
  • Signal Transduction
  • Triglycerides / metabolism

Substances

  • Acetates
  • Cyclooxygenase Inhibitors
  • Membrane Proteins
  • Pyrazines
  • Receptors, Prostaglandin
  • Receptors, Prostaglandin E, EP4 Subtype
  • Triglycerides
  • prostaglandin F2alpha receptor
  • Arachidonic Acid
  • 6-Ketoprostaglandin F1 alpha
  • Dinoprost
  • Cyclic AMP
  • (4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid
  • Hydroxyprostaglandin Dehydrogenases
  • prostaglandin-F synthase
  • Ptgs2 protein, mouse
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, mouse
  • Prostaglandin-E Synthases
  • Ptges protein, mouse
  • Dinoprostone
  • 1-Methyl-3-isobutylxanthine